MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/102.5/0.1/21.03.25 Stock

Warrant

DE000MG4PAP5

Market Closed - Börse Stuttgart 03:12:29 2024-07-04 pm EDT
0.072 EUR -4.00% Intraday chart for MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/102.5/0.1/21.03.25
Current month-20.00%
1 month-33.33%
Date Price Change
24-07-04 0.072 -4.00%
24-07-03 0.075 -5.06%
24-07-02 0.079 -12.22%
24-07-01 0.09 0.00%
24-06-28 0.09 -4.26%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 03:12 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
Issuer Morgan Stanley
WKN MG4PAP
ISINDE000MG4PAP5
Date issued 2024-05-23
Strike 102.5 $
Maturity 2025-03-21 (260 Days)
Parity 10 : 1
Emission price 0.15
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.121
Lowest since issue 0.07
Spread 0.022
Spread %23.40%

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
154.5 USD
Average target price
174.6 USD
Spread / Average Target
+12.95%
Consensus